Scottish Medicines Consortium approves three cancer drugs for NHS use
The three approved drugs are AstraZeneca’s olaparib, Bristol-Myers Squibb’s nivolumab and AbbVie’s ibrutinib.
Scotland
Latest in
Scotland
University of Glasgow to establish Covid-19 drug screening hub
The MRC-University of Glasgow Centre for Virus Research (CVR) is set to establish a Covid-19 drug screening and resistance hub…
SMC accepts Janssen’s ulcerative colitis drug Stelara for NHS use
Scottish Medicines Consortium (SMC) has accepted Janssen Pharmaceutical's Stelara (ustekinumab) for use on the National Health Service (NHS) Scotland to…
Coronavirus: COVID-19 UK outbreak, measures and impact
The UK confirmed its first 2019-nCoV (now COVID-19) infection case, following France and Germany, on 31 January 2020 and has…
Scotland reaches access agreement with Vertex for CF drug Orkambi
Vertex Pharmaceuticals has announced two of its cystic fibrosis (CF) drugs, Orkambi (lumacaftor-ivacaftor) and Symkevi (tezacaftor/ivacaftor) will now be available…
ByEisai forms PROTACs research collaboration
Eisai has formed a research collaboration to support oncology drug discovery using proteolysis targeting chimeras (PROTAC), which comprise two covalently linked…
Deals this week: Medicines for Malaria Venture, Swedish Orphan Biovitrum, aTyr Pharma
Medicines for Malaria Venture (MMV) has entered a collaboration with Drugs for Neglected Disease initiative (DNDi) to create a pandemic…
Pharmaceutical industry worth £1.7bn to Scottish economy
Scotland's pharmaceutical sector is worth £1.7bn (gross value added) to the country’s economy, according to a report by the Fraser…